Detalles de la búsqueda
1.
Nuclear upregulation of class I phosphoinositide 3-kinase p110ß correlates with high 47S rRNA levels in cancer cells.
J Cell Sci
; 134(3)2021 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33536247
2.
Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: a retrospective study.
BMC Cancer
; 19(1): 547, 2019 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31174495
3.
Blood steroids are associated with prognosis and fat distribution in endometrial cancer.
Gynecol Oncol
; 152(1): 46-52, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30554934
4.
Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions.
Gynecol Oncol
; 148(1): 197-203, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29096882
5.
Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer.
Acta Radiol
; 59(8): 1010-1017, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29137496
6.
Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients.
Br J Cancer
; 117(6): 840-847, 2017 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28751757
7.
Expression of glucocorticoid receptor is associated with aggressive primary endometrial cancer and increases from primary to metastatic lesions.
Gynecol Oncol
; 147(3): 672-677, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28927900
8.
Blood Metabolites Associate with Prognosis in Endometrial Cancer.
Metabolites
; 9(12)2019 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31847385
9.
Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study.
Hum Pathol
; 89: 90-98, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31054899
10.
Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer.
PLoS One
; 13(11): e0206665, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30383835
11.
High visceral fat percentage is associated with poor outcome in endometrial cancer.
Oncotarget
; 8(62): 105184-105195, 2017 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29285243
12.
Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers.
Oncotarget
; 8(40): 68530-68541, 2017 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28978135
13.
PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer.
Sci Rep
; 7(1): 10240, 2017 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-28860563
14.
Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer.
Oncotarget
; 7(43): 69844-69856, 2016 Oct 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27634881
15.
ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma.
Oncotarget
; 6(29): 28440-52, 2015 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26308378
16.
Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients.
Oncotarget
; 6(2): 1327-39, 2015 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25415225
17.
Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer.
PLoS One
; 9(2): e90141, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24587245
Resultados
1 -
17
de 17
1
Próxima >
>>